The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-15
DOI
10.1186/s12885-019-5638-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
- (2017) Shinya Oki et al. Oncotarget
- MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication
- (2016) Debra L. Evans et al. CELL CYCLE
- Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer
- (2016) Agapiti Hipoliti Chuwa et al. GYNECOLOGIC ONCOLOGY
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
- (2015) Yuji Ikeda et al. BRITISH JOURNAL OF CANCER
- The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition
- (2015) Tomohiko Fukuda et al. GYNECOLOGIC ONCOLOGY
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
- (2015) Changping Wu et al. Oncotarget
- Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway
- (2015) Gouji Toyokawa et al. NEOPLASIA
- Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
- (2014) Aki Miyasaka et al. BMC CANCER
- WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck
- (2014) Vassiliki Saloura et al. MOLECULAR CANCER RESEARCH
- Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
- (2014) Tomoko Kashiyama et al. PLoS One
- Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair
- (2014) Kenbun Sone et al. Nature Communications
- Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma
- (2013) Shanshan Yang et al. BIOMARKERS
- Overexpression of MMSET in endometrial cancer: A clinicopathologic study
- (2012) Min Xiao et al. JOURNAL OF SURGICAL ONCOLOGY
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma
- (2012) Peng Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- Cancers and the NSD family of histone lysine methyltransferases
- (2011) Masayo Morishita et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma
- (2011) H. R. Hudlebusch et al. CANCER RESEARCH
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors
- (2011) H. R. Hudlebusch et al. CLINICAL CANCER RESEARCH
- Histone lysine methylation and demethylation pathways in cancer
- (2010) Radhika A. Varier et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
- (2008) M. TAKANO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation